<?xml version='1.0' encoding='utf-8'?>
<document id="28650333"><sentence text="Simultaneous determination of ACE inhibitors and dexibuprofen in active pharmaceutical ingredient, formulations and human serum by RP-HPLC."><entity charOffset="49-61" id="DDI-PubMed.28650333.s1.e0" text="dexibuprofen" /></sentence><sentence text="The contemporary work describes a rapid and cost effective reversed phase High Performance Liquid Chromatography (RP-HPLC) method for the quantification of Captopril, Lisinopril and Dexibuprofen (DXP) simultaneously in dosage formulations, active pharmaceutical ingredients and human serum"><entity charOffset="156-165" id="DDI-PubMed.28650333.s2.e0" text="Captopril" /><entity charOffset="167-177" id="DDI-PubMed.28650333.s2.e1" text="Lisinopril" /><entity charOffset="182-194" id="DDI-PubMed.28650333.s2.e2" text="Dexibuprofen" /><entity charOffset="196-199" id="DDI-PubMed.28650333.s2.e3" text="DXP" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e0" e2="DDI-PubMed.28650333.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e0" e2="DDI-PubMed.28650333.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e0" e2="DDI-PubMed.28650333.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e0" e2="DDI-PubMed.28650333.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e1" e2="DDI-PubMed.28650333.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e1" e2="DDI-PubMed.28650333.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e1" e2="DDI-PubMed.28650333.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e2" e2="DDI-PubMed.28650333.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28650333.s2.e2" e2="DDI-PubMed.28650333.s2.e3" /></sentence><sentence text=" The chromatographic system included LC-20A pump, Sil-20A auto sampler and SPD-20A UV/visible detector" /><sentence text=" The estimation was carried out by using a C18 (5μm, 250 ×4" /><sentence text="6 mm) column with mobile phase methanol: water (80:20 v/v, pH 3"><entity charOffset="31-39" id="DDI-PubMed.28650333.s5.e0" text="methanol" /></sentence><sentence text="0) at 230 nm with a flow rate of 1" /><sentence text="0 ml•min-1" /><sentence text=" The retention time of Dexibuprofen was 5"><entity charOffset="23-35" id="DDI-PubMed.28650333.s8.e0" text="Dexibuprofen" /></sentence><sentence text="4 min while that of Captopril and Lisinopril were found to be 3"><entity charOffset="20-29" id="DDI-PubMed.28650333.s9.e0" text="Captopril" /><entity charOffset="34-44" id="DDI-PubMed.28650333.s9.e1" text="Lisinopril" /><pair ddi="false" e1="DDI-PubMed.28650333.s9.e0" e2="DDI-PubMed.28650333.s9.e0" /><pair ddi="false" e1="DDI-PubMed.28650333.s9.e0" e2="DDI-PubMed.28650333.s9.e1" /></sentence><sentence text="2 and 1" /><sentence text="8 minutes respectively" /><sentence text=" There was no considerable variation exists in between the tested drug spiked in serum and the extent recovered, without interference of serum in concurrent approximation" /><sentence text=" The method developed was found to be precise, selective and validated for precision, linearity, specificity, accuracy, limit of detection and limit of quantitation" /><sentence text=" There is no such method reported earlier for the determination of ACE Inhibitors and DXP simultaneously"><entity charOffset="86-95" id="DDI-PubMed.28650333.s14.e0" text="DXP" /></sentence><sentence text=" The present study helps in assessing the co-administration of both drugs in treatment and can be employed for quality control analysis and drug-drug interaction studies" /><sentence text="" /></document>